Venus Remedies Joins United Nations Global Compact
Mumbai: Venus Remedies Limited, a leading research-driven global pharmaceutical company, has joined the United Nations Global Compact (UNGC), the world’s largest corporate sustainability initiative. This strategic move aligns the company’s operations and strategies with the UNGC’s Ten Principles on human rights, labor, environment, and anti-corruption.
Commitment to Sustainable Global Healthcare
By joining the UNGC, Venus Remedies reaffirms its commitment to responsible healthcare innovation, ethical governance, and environmental stewardship. The company has implemented a comprehensive Environmental, Social, and Governance (ESG) strategy across its international operations and has obtained ISO 14064-1 certification for greenhouse gas emissions reporting.
Enhancing Global Impact
Venus Remedies has been a long-standing supplier of WHO-prequalified pharmaceuticals to international health agencies and has secured key supply contracts with UNICEF and the Pan American Health Organization (PAHO). The company’s commitment to Sustainable Development Goal 3 (SDG 3) and its ESG-led innovation roadmap focuses on antimicrobial resistance (AMR) as a critical area of research and development.
Driving Innovation and Collaboration
The company’s novel polymyxin B formulation, VRP-034, has been granted Qualified Infectious Disease Product (QIDP) designation by the U.S. Food and Drug Administration. Venus Remedies also plays a key role in advancing AMR surveillance and global policy development through initiatives like GASAR and the PLEA Trust.
Global Recognition and Quality Standards
Venus Remedies holds Good Manufacturing Practice (GMP) approvals from several leading authorities and internationally recognized ISO certifications in quality management, environmental management, and occupational health and safety. The company’s strategic collaborations with national regulators, international donors, and institutional buyers continue to amplify its impact in delivering affordable and quality-assured therapeutics.
